Sanctuary Advisors LLC Makes New Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Sanctuary Advisors LLC acquired a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 3,687 shares of the company’s stock, valued at approximately $428,000.

Several other institutional investors also recently bought and sold shares of ADUS. Virtu Financial LLC purchased a new position in Addus HomeCare during the 4th quarter worth $322,000. Wellington Management Group LLP increased its holdings in Addus HomeCare by 1.2% during the 4th quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock worth $74,135,000 after purchasing an additional 9,548 shares during the period. Vanguard Group Inc. boosted its position in Addus HomeCare by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after acquiring an additional 38,876 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Addus HomeCare by 40.8% in the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after acquiring an additional 161 shares during the period. Finally, Bridge City Capital LLC increased its holdings in shares of Addus HomeCare by 46.4% in the 1st quarter. Bridge City Capital LLC now owns 30,999 shares of the company’s stock valued at $3,203,000 after acquiring an additional 9,819 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ADUS has been the topic of a number of analyst reports. Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Macquarie reiterated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Friday, October 11th. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Stephens reiterated an “overweight” rating and issued a $138.00 price target on shares of Addus HomeCare in a report on Tuesday, August 6th. Finally, KeyCorp initiated coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $131.38.

Addus HomeCare Price Performance

Shares of ADUS stock opened at $132.76 on Thursday. Addus HomeCare Co. has a 1-year low of $78.35 and a 1-year high of $136.12. The stock’s fifty day moving average price is $130.16 and its 200 day moving average price is $117.84. The company has a market cap of $2.40 billion, a price-to-earnings ratio of 32.94, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.94 EPS. As a group, equities research analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,917 shares of company stock worth $3,050,082. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.